Abstract: There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.

Abstract: A video signal processing apparatus may include a first analog-to-digital converter (ADC) configured to convert an analog video signal into a first digital video signal according to a first clock; and/or a second ADC configured to convert the analog video signal into a second digital video signal according to a second clock that is different from the first clock. The first and second clocks may have a first phase difference in a first section of the analog video signal, such that the first and second ADCs operate alternately, first ADC then second ADC, and the first and second clocks may be generated to have a second phase difference, that is different from the first phase difference, in a second section of the analog video signal that is different from the first section, such that the first and second ADCs operate alternately, second ADC then first ADC.

Abstract: The disclosure is related to measuring macrocell quality of a macrocell using femtocells. A method may be provided for measuring macrocell quality of at least one macrocell using a femtocell base station. The method may include measuring, by the femtocell base station, macrocell quality of at least one macrocell based on event information, generating macrocell quality report information based on a result of the measuring, and transmitting the generated macrocell quality report information to a server through a femtocell gateway. The measuring macrocell quality may include determining whether a macrocell identifier is present in the event information, measuring the macrocell quality of a target macrocell corresponding to the mermen identifier of the event when the macrocell identifier is present in the event information, and measuring the macrocell quality of substantially all neighbor macrocells when the macrocell identifier is absent from the event information.

Abstract: Disclosed is a method for treating or preventing anemia. The method includes administering a testis extract serving as an active ingredient for treating or preventing anemia to a mammal. The testis extract is extracted by chloroform and methanol mixed solvent. The testis extract includes nandrolone, testosterone, androstenedione, estradiol, and estrone. The testis extract is prepared by using a method including: adding an extraction solvent to a testis to homogenize; filtering the homogenized mixing solution to remove residues; fractionating a filtrate without the residue to separate a supernatant and a under layer; removing water from the separated under layer; and concentrating an extract without water.

Abstract: The disclosure is related to handover for user equipment between femtocell base stations having different closed subscriber group (CSG) identifiers. A method may be provided for allowing handover of user equipment between base stations belonging to different organizations. The method may include collecting, by a first base station, information corresponding to identifiers of neighbor base stations, selecting handover-allowable base stations from the neighbor base stations having an organization identifier different from that of the first base station, and enabling handover for the user equipment from the first base station to a second base station based on the selected handover-allowable base stations for a handover request of the user equipment from the first base station to the second base station.

Abstract: Provided are femtocell base stations and a management system therefor establishing an X2 interface between femtocell base stations. The method may include obtaining, by the femtocell base station, an Internet Protocol (IP) address of one or more neighbor femtocell base stations, and establishing the X2 interface between the femtocell base station and the neighbor femtocell base station using the corresponding, obtained IP address.

Abstract: There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I): or any of their isomers, or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions containing the subject compounds. The subject compounds are useful for the treatment of diseases of the central nervous system, particularly depression, anxiety and pain disorder.

Abstract: The present invention relates to an anti-adhesive agent containing hyaluronic acid and L-arginine, which has increased in vivo residence time and excellent anti-adhesive properties. According to the present invention, adhesion can be prevented from occurring due to surgical operation, infection and trauma.

Abstract: There is provided a novel carbamoyloxy arylalkanoyl arylpiperazine derivative compound having abundant racemic or enantiomeric characteristics, represented by the Formula 1, and pharmaceutically available salts or hydrates thereof. Also, there are provided a pharmaceutical composition for treating pain, anxiety or depression including an effective amount of the compound, and a method for treating pain, anxiety or depression in mammals by administering an effective amount of the compound to the mammals in need of treatment thereof.

Abstract: There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I): or any of their isomers, or pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions containing the subject compounds. The subject compounds are useful for the treatment of diseases of the central nervous system, particularly depression, anxiety and pain disorder.

Abstract: The front-end integrated circuit includes a first clock unit receiving a reference clock signal from an oscillator and generating a first clock signal, a first analog front end module receiving and processing a first broadcast signal using the first clock signal, a second clock unit receiving the reference clock signal and generating a second clock signal, and a second analog front end module receiving and processing a second broadcast signal using the second clock signal.

Abstract: Provided is a composition containing placenta extracts as active ingredients. Placenta extracts are natural substances extracted from placentas of livestock and show effects that can replace steroids and reduce adverse effects of steroids, so that placenta extracts have a wide range of applications including contraceptives, anti-osteoporosis drugs, anti-anemic drugs, therapeutic agents for wasting diseases of muscular atrophy, agents for treating sexual dysfunction, therapeutic agents for wounds, and adipocyte differentiation stimulating agents for improving meat quality of livestock, etc.

Abstract: Described embodiments provide a method for processing an uplink signal in a radio unit. A first uplink signal may be received directly from user equipment. The received uplink signal may be delayed using uplink delay information. A second uplink signal may be received indirectly from user equipment through at least one repeater connected to the radio unit. The delayed first uplink signal and the second uplink signal may be combined and transmitted to a digital unit.

Abstract: Described embodiments provide a method of a circuit switched (CS) fallback procedure at a first network providing only a packet switched (PS) service. A CS fallback procedure may be initiated upon a receipt of a call associated with a CS service. One of carriers assigned to a second network that provides a circuit switched (CS) service may be selected. Then, a second network cell mapped to a serving cell of the first network and using the selected carrier may be selected as a target cell. The user equipment may be handed over o to the selected second network cell in order to provide a requested CS service.

Abstract: Described embodiments provide a method of effectively selecting a target cell to hand over user equipment from a LTE network to a non-LTE network when the user equipment requests a CS service. A LTE cell may determine a CS fallback hysteresis parameter in advance. The LTE cell may receive signal quality measurements of at least two candidate non-LTE cells from the user equipment. The LTE cell may select one target cell among the at least two candidate non-LTE cells based on the CS fallback hysteresis parameter and the received signal quality measurements of the at least two candidate non-LTE cells.

Abstract: Described embodiments provide controlling signal transmission in a plurality of radio units. The plurality of radio units may be coupled to a digital unit. The digital unit may be spatially separated from the plurality of radio units. Signal quality measurements may be received from multiple radio units when a user equipment is located within an overlapping service area of the multiple radio units. Determination may be made as to whether to simultaneously use at least two of the multiple radio units to transmit a data signal to the user equipment based on the received signal quality measurements. At least two of the multiple radio units may be controlled to transmit a same data signal to the user equipment using a same channel based on the determination result.

Abstract: The present invention relates to a pharmaceutical composition including a testis extract serving as an active ingredient for treating and preventing anemia, in which since the testis extract induces proliferation of hematopoietic stem cell, an increase in the number of red blood cell, and an increase in the amount of hemoglobin, it is effectively used as a therapeutic agent for treating anemia related to red blood cell and hemoglobin in women of childbearing age, post-childbearing age, and during pregnancy, as well as in men.

Abstract: Provided is an analog front end of a digital TV, a digital TV system having the same, and a method of operating the same. The analog front end includes: a first selection circuit which selectively outputs differential sound intermediate frequency signals or differential TV broadcast signals in response to a first selection signal; a second selection circuit which outputs a clock signal among a plurality of clock signals having a different sampling frequencies, in response to a second selection signal; and an analog-to-digital converter which converts output signals output from the first selection circuit to a digital code, according to a sampling frequency of a clock signal output from the second selection circuit.

Abstract: The disclosure is related to handover for user equipment between femtocell base stations having different closed subscriber group (CSG) identifiers. A method may be provided for allowing handover of user equipment between base stations belonging to different organizations. The method may include collecting, by a first base station, information corresponding to identifiers of neighbor base stations, selecting handover-allowable base stations from the neighbor base stations having an organization identifier different from that of the first base station, and enabling handover for the user equipment from the first base station to a second base station based on the selected handover-allowable base stations for a handover request of the user equipment from the first base station to the second base station.

Abstract: The disclosure is related to measuring macrocell quality of a macrocell using femtocells. A method may be provided for measuring macrocell quality of at least one macrocell using a femtocell base station. The method may include measuring, by the femtocell base station, macrocell quality of at least one macrocell based on event information, generating macrocell quality report information based on a result of the measuring, and transmitting the generated macrocell quality report information to a server through a femtocell gateway. The measuring macrocell quality may include determining whether a macrocell identifier is present in the event information, measuring the macrocell quality of a target macrocell corresponding to the mermen identifier of the event when the macrocell identifier is present in the event information, and measuring the macrocell quality of substantially all neighbor macrocells when the macrocell identifier is absent from the event information.